Soccernet.ng kept tabs on dozens of matches potentially featuring Nigerian footballers across different leagues worldwide on Sunday, May 26, 2024. Algeria Tosin Omoyele scored his sixth goal of the season to power Khenchela to a hard…
Raja Foods LLC of Skokie, Il, is recalling its 3.5-ounce packages of “Swad Cinnamon Powder” because it has the potential to be contaminated with lead. The products included in this recall are, Swad Brand Cinnamon Powder in clear plastic 3…
Medtronic Plc (NYSE: MDT) says the FDA Circulatory System Devices Panel (CSDP) voted unanimously (13-0) on safety and in favor (7-6) of the effectiveness of the Symplicity blood pressure procedure, Spyral Renal Denervation (RDN) System.
A US Food and Drug Administration (FDA) panel of advisors has unanimously recommended that updated COVID-19 vaccines being developed for the autumn vaccination campaign target one of the currently circulating XBB variants. The advisory…
The action follows a key advisory committee's 21-0 vote that a new vaccine should focus on just one strain of the virus, and not be a bivalent shot as before.
Outside advisers to the Food and Drug Administration (FDA) on Friday unanimously recommended the agency grant full approval to a new kind of Alzheimer's drug that modestly slows cognitive decline in early-stage patients. The panel voted 6…
Paris, June 8, 2023. The U.S. Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously 21 to 0 that Sanofi and AstraZeneca's nirsevimab has a favorable benefit risk profile for the prevention of…
In a unanimous vote, 17-0, a panel of advisers to the Food and Drug Administration recommended that the agency approve the first over-the-counter birth control pill.
The FDA's Antimicrobial Drugs Advisory Committee unanimously voted 12-0 in support of approval of Innoviva Inc's (NASDAQ: INVA) sulbactam-durlobactam for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia…
The FDA's Peripheral and Central Nervous System Drugs Advisory Committee voted 9 yes - 0 no, indicating sufficient evidence showing a reduction in plasma neurofilament light chain (NfL) concentration in tofersen-treated patients is…
The FDA's Vaccines and Related Biological Products Advisory Committee voted that GSK plc's (NYSE: GSK) available data support the safety and effectiveness of its respiratory syncytial virus (RSV) candidate to prevent lower respiratory…
The anti-opioid overdose drug Narcan should be made available for over-the-counter use, advisers to the Food and Drug Administration said Wednesday. A joint FDA advisory panel unanimously voted 19-0 to recommend the agency approve the drug…
The primary endpoint is the proportion of patients with a good outcome as a modified Rankin Score (mRS) of 0-2 on day 90 post-randomization Sovateltide is an endothelin-B receptor agonist that has been shown to increase blood flow, inhibit…
TransCode Therapeutics Inc (NASDAQ: RNAZ) has received written authorization from the FDA to proceed with its First-in-Human (FIH) Phase 0 clinical trial.; The planned clinical trial is to evaluate TransCode's lead therapeutic candidate,…
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 16-0 that Y-mAbs had not provided sufficient evidence to conclude that omburtamab improved overall survival despite positive results from two studies, the single-arm, Phase I Study…
A Food and Drug Administration (FDA) advisory panel on Tuesday recommended the agency expand the authorization of Moderna's COVID-19 vaccine to children and teenagers ages 6 to 17. The vaccine is currently approved for adults only. The…
FDA advisers voted 21-0 in favor of the Novavax COVID vaccine, which is based on older, more conventional technology than mRNA shots. Advocates for this shot see it as likely to win over some vaccine-hesitant people. Medscape Medical News
Novavax, Inc. (NASDAQ: NVAX) announced the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 21 to 0, with one abstention, to recommend that the FDA grant Emergency Use…
An outside advisory panel voted overwhelmingly to recommend the Food and Drug Administration (FDA) authorize a COVID-19 vaccine made by Novavax for use in adults, a move that could lead to adding a fourth vaccine to the U.S. arsenal. The…